Multimodal neuroimaging in Alzheimer's disease: A practical, case-illustrated review of quantitative MRI and molecular PET
Journal of Alzheimer’s Disease · 13.11.2026
DOI: 10.1177/13872877261505047 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Alzheimer’s Disease, online erschienen am 13.11.2026. Verfasst von Iman Dajani und 2 weiteren Autor:innen. Beteiligte Einrichtung: Weill Cornell Medicine-Qatar, Qatar Foundation, Education City, Doha, Qatar. Die Arbeit nennt 51 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer's disease (AD) accounts for 60–70% of dementia cases worldwide. Current diagnostic pathways rely on structural magnetic resonance imaging (MRI) to exclude secondary causes, amyloid positron emission tomography (PET) to confirm pathology, and tau PET for disease staging. However, these approaches are limited by subjectivity, cost, accessibility, and variability in interpretation. Quantitative imaging tools such as volumetric MRI and NeuroQuant offer reproducible metrics that may enhance diagnostic precision and standardization. This review synthesizes literature published between 2000 and 2026 evaluating structural MRI, quantitative volumetric MRI, amyloid PET, tau PET, FDG PET, and emerging adjunctive imaging techniques, supplemented by illustrative clinical cases demonstrating multimodal integration in practice. Particular emphasis is placed on the role of NeuroQuant in standardized atrophy quantification and its integration with molecular imaging modalities. Volumetric MRI enhances PET-based diagnosis and staging by contextualizing amyloid and tau pathology within patterns of selective neurodegeneration. Quantitative metrics correlate with cognitive decline and disease progression. Multimodal imaging strategies improve diagnostic specificity, longitudinal monitoring, and phenotypic stratification across the AD. Multimodal imaging provides a comprehensive framework for AD management. Quantitative MRI using NeuroQuant bridges structural and molecular domains, supporting standardized assessment and integration with emerging precision diagnostic approaches.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Weill Cornell Medicine-Qatar, Qatar Foundation, Education City, Doha, Qatar.
- Advocate Lutheran General Hospital, Advocate-Aurora Healthcare, Park Ridge, IL, USA.
ORCID-Profile: Iman Dajani, Ali Chaari
Zitieren
APA
Dajani, I., Alsheik, N., & Chaari, A. (2026). Multimodal neuroimaging in Alzheimer's disease: A practical, case-illustrated review of quantitative MRI and molecular PET. Journal of Alzheimer’s Disease. https://doi.org/10.1177/13872877261505047
Vancouver
Dajani I, Alsheik N, Chaari A. Multimodal neuroimaging in Alzheimer's disease: A practical, case-illustrated review of quantitative MRI and molecular PET. Journal of Alzheimer’s Disease. 2026. doi:10.1177/13872877261505047
BibTeX
@article{Dajani2026,
author = {Dajani, Iman and Alsheik, Nila and Chaari, Ali},
title = {Multimodal neuroimaging in Alzheimer's disease: A practical, case-illustrated review of quantitative MRI and molecular PET},
journal = {Journal of Alzheimer’s Disease},
year = {2026},
doi = {10.1177/13872877261505047}
}
EUVIMED